Search

Your search keyword '"angiotensin converting enzyme 2"' showing total 612 results

Search Constraints

Start Over You searched for: Descriptor "angiotensin converting enzyme 2" Remove constraint Descriptor: "angiotensin converting enzyme 2"
612 results on '"angiotensin converting enzyme 2"'

Search Results

1. Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats

2. 敲减miR-296-5p通过激活ACE2信号通路减轻 脑梗死后神经功能损伤.

Catalog

Books, media, physical & digital resources

3. Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.

4. Angiotensin Converting Enzyme-2 (ACE-2): A Target for Novel Drug Development

5. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.

6. Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study

7. 血清多配体蛋白聚糖 1、血管紧张素转换酶 2 与川崎病患儿冠状动脉损害和临床疗效的关系.

8. Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study.

10. Extracellular vesicles and angiotensin-converting enzyme 2 in COVID-19 disease.

11. Expression of angiotensin converting enzyme 2 in patients with oral squamous cell carcinoma

12. Analysis of the Glycoprotein Properties and Glycan Structures of Chicken Angiotensin Converting Enzyme 2.

13. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms

14. The consequential impact of JUUL on youth vaping and the landscape of tobacco products: The state of play in the COVID-19 era.

15. The classical and alternative circulating renin‐angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease

16. Identification of Leading Compounds from Euphorbia neriifolia (Dudsor) Extracts as a Potential Inhibitor of SARS-CoV-2 ACE2-RBDS1 Receptor Complex: An Insight from Molecular Docking ADMET Profiling and MD-simulation Studies.

17. Decreased Heart Rate Variability in COVID-19

18. 基于 CRISPR/Cas9 技术构建与鉴定敲除 ACE2 基因的 Huh7 肝癌细胞株.

19. PERINDOPRIL AND LOSARTAN ATTENUATE PRO-COAGULATION FACTORS IN HUMAN ADIPOCYTES EXPOSED TO SARS-COV-2 SPIKE PROTEIN.

20. COVID-19 pneumonia: Perfusion abnormalities shown on subtraction CT angiography in apparently well-ventilated lungs. A prospective cohort study

21. Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review

22. High D-glucose levels induce ACE2 expression via GLUT1 in human airway epithelial cell line Calu-3

23. Comparison between Vitamin-D and Urinary Angiotensin Converting Enzyme Levels in Type 2 Diabetic Hypertensive Patients with Non-Diabetic Hypertensive Patients

24. Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant.

26. Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review.

27. Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019

28. Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease.

29. Fluorescence-Based Measurements of Membrane-Bound Angiotensin Converting Enzyme 2 Activity Using Xenopus Laevis Oocytes.

30. High D-glucose levels induce ACE2 expression via GLUT1 in human airway epithelial cell line Calu-3.

31. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.

32. Pharmacologic Treatment, Modeling Of Virtual Database Screening Of Viruses and Drug Targets For Coronavirus Disease (2019 N-Cov).

33. Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy

34. Characterization of novel ACE2 mRNA transcripts: The potential role of alternative splicing in SARS-CoV-2 infection.

35. The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis

36. Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue

37. Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension.

38. Activation of angiotensin converting enzyme 2 promotes hippocampal neurogenesis via activation of Wnt/β-catenin signaling in hypertension.

39. Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.

40. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.

41. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019

42. Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019

43. Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2

44. Modeling Substrate Coordination to Zn-Bound Angiotensin Converting Enzyme 2.

45. The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.

46. ACE2 Shedding and the Role in COVID-19.

47. Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy.

48. 2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications

49. Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19

50. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents